Literature DB >> 3123240

"Cerebral" lactic acidosis: defects in pyruvate metabolism with profound brain damage and minimal systemic acidosis.

G K Brown1, E A Haan, D M Kirby, R D Scholem, J E Wraith, J G Rogers, D M Danks.   

Abstract

Six patients are described with a combination of early onset of neurological symptoms, gross cerebral changes and elevated concentrations of pyruvate and lactate in cerebrospinal fluid. Although at least five of the six patients appear to have a generalised defect in pyruvate metabolism, reflected in deficient pyruvate dehydrogenase activity in cultured fibroblasts, systemic acidosis was not a problem clinically and blood pyruvate and lactate concentrations were only slightly raised. The localisation of significant clinical and biochemical problems to the central nervous system, coupled with the difficulties in making the diagnosis if analysis of cerebrospinal fluid (CSF) is not performed, lead us to term this condition "cerebral" lactic acidosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123240     DOI: 10.1007/bf00442603

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  A study of some oxidative enzymes of baker's yeast.

Authors:  L SMITH
Journal:  Arch Biochem Biophys       Date:  1954-06       Impact factor: 4.013

Review 2.  Disorders of the pyruvate dehydrogenase complex.

Authors:  D Stansbie; S J Wallace; C Marsac
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

3.  Detection of life threatening inborn errors of metabolism during infancy.

Authors:  P T Tippett; D M Danks; L Dimech
Journal:  Aust Paediatr J       Date:  1973-12

4.  Human mitochondrial electron transport chain: assay of succinate: cytochrome c reductase in leukocytes, platelets and cultured fibroblasts.

Authors:  D A Stumpf; J K Parks
Journal:  Biochem Med       Date:  1981-04

5.  Pyruvate carboxylase and phosphoenolpyruvate carboxykinase activity in leukocytes and fibroblasts from a patient with pyruvate carboxylase deficiency.

Authors:  B M Atkin; M F Utter; M B Weinberg
Journal:  Pediatr Res       Date:  1979-01       Impact factor: 3.756

6.  Neuropathology in cerebral lactic acidosis.

Authors:  C W Chow; R M Anderson; G C Kenny
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

7.  Malonyl coenzyme A decarboxylase deficiency.

Authors:  G K Brown; R D Scholem; A Bankier; D M Danks
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Immunochemical analysis of normal and mutant forms of human pyruvate dehydrogenase.

Authors:  C A Wicking; R D Scholem; S M Hunt; G K Brown
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

9.  Pyruvate dehydrogenase deficiency restricted to brain.

Authors:  M Prick; F Gabreëls; W Renier; F Trijbels; H Jaspar; K Lamers; J Kok
Journal:  Neurology       Date:  1981-04       Impact factor: 9.910

10.  The genetic heterogeneity of lactic acidosis: occurrence of recognizable inborn errors of metabolism in pediatric population with lactic acidosis.

Authors:  B H Robinson; J Taylor; W G Sherwood
Journal:  Pediatr Res       Date:  1980-08       Impact factor: 3.756

View more
  37 in total

1.  Primary pyruvate dehydrogenase E3 binding protein deficiency with mild hyperlactataemia and hyperalaninaemia.

Authors:  I P Hargreaves; S J R Heales; A Briddon; P J Lee; M G Hanna; J M Land
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 2.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

3.  Polymorphisms in the human X-linked pyruvate dehydrogenase E1 alpha gene.

Authors:  H H Dahl; W M Hutchison; Z Guo; S M Forrest; L L Hansen
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

4.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

Review 5.  Laboratory approach to mitochondrial diseases.

Authors:  D Parra; A González; C Mugueta; A Martínez; I Monreal
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

6.  A case of PDH-E1 alpha mosaicism in a male patient with severe metabolic lactic acidosis.

Authors:  A Seyda; K Chun; S Packman; B H Robinson
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

7.  Heterogeneous tissue expression of enzyme defects in mitochondrial myopathies.

Authors:  W Sperl; W Ruitenbeek; J M Trijbels; G C Korenke; R C Sengers
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

8.  Cytochrome c oxidase deficiency in subacute necrotizing encephalopathy (Leigh syndrome).

Authors:  K Hayasaka; G K Brown; D M Danks; M Droste; B Kadenbach
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

9.  The locus for pyruvate dehydrogenase E1 alpha subunit (Pdha1) lies between Plp and Amg on the mouse X chromosome.

Authors:  H J Blair; V Reed; S H Laval; Y Boyd
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

Review 10.  Pyruvate dehydrogenase E1 alpha deficiency.

Authors:  G K Brown
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.